Rare Diseases
Opinion
Dodging potholes from cancer care to hospice transitions
The consequences of suboptimal hospice transitions can damage the mental health and well-being of patient and caregiver.
Latest News
New data confirm risk of Guillain-Barré with J&J COVID shot
Nearly all individuals who developed GBS after the Janssen vaccine had facial weakness or paralysis, in addition to weakness and decreased...
Guidelines
New guideline sheds light on diagnosis, treatment of rare GI syndromes
The U.S. Multi-Society Task Force on Colorectal Cancer provides 14 recommendations for the genetic evaluation, surveillance, and treatment of...
Conference Coverage
Dupilumab treats itch and clears lesions in prurigo nodularis patients
There are currently no Food and Drug Administration–approved systemic therapies for PN.
Conference Coverage
Novel isotretinoin ointment for congenital ichthyosis shows promise
“There is currently no FDA-approved drug for congenital ichthyosis,” Dr. Christopher G. Bunick said.
Latest News
High early recurrence rates with Merkel cell carcinoma
Approximately 95% of all recurrences happened within 3 years of the initial diagnosis in the prospective cohort study.
Latest News
U.S. FDA declines to approve Amryt’s topical gel for rare skin diseases
The decision comes after the FDA had extended its review of the treatment, oleogel-S10, in November by three months to review additional analyses...
Feature
Cystic fibrosis in retreat, but still unbeaten
Latest News
Lipedema: A potentially devastating, often unrecognized disease
“If patients with lipedema gain weight, the problem becomes even worse,” Dr. C. William Hanke said.
Latest News
Superficial radiotherapy tied to remission, better quality of life in severe Hailey-Hailey disease
To explore the use of superficial radiotherapy, the investigators analyzed data on 13 patients who received the treatment.
News
FDA approves levoketoconazole for Cushing syndrome
The drug, which inhibits cortisol synthesis, is seen as addressing an unmet need.